cisplatin,fluorouracil,sintilimab,paclitaxel
eli lilly,innovent biologics
['sintilimab', 'orient-15', 'orien', 'esophageal', 'innovent', '$ivbxf']
$ivbxf - innovent releases final analysis results of orient-15: the phase 3 study of sintilimab plus chemotherapy for the first-line treatment of esophageal squamous cell carcinoma at the aacr annual meeting 2023 
Follow for the latest #healthcare #stockmarket tweets. Visit https://t.co/wA5OfUn0Ee to try our powerful investing tools.